Skip to content
OpenCapital
Get started

4D Molecular Therapeutics FDMT Increase Decrease In Derivative Liabilities

Increase Decrease In Derivative Liabilities at other companies

PVL
Palvella TherapeuticsPVLA
$116K+54.7%

Other financials

Income statement

See full
Revenue$3.0M+21,664%
Operating income-$73.6M-37.3%
Net income-$68.8M-43.3%
EPS (diluted)-$1.01-17.4%

Balance sheet

See full
Cash & equivalents$72.5M-45.7%
Total debt$20.5M-13.9%
Total equity$451.8M-3.8%
Total assets$512.9M-0.5%

Cash flow

See full
Operating cash flow-$68.1M-42.6%
CapEx--100%
Free cash flow-$68.1M-40.8%

Valuation

See full
Market cap$602.22M+215%
Enterprise value$550.27M+574%
P/S6.8×-8,306×

Profitability

See full
Operating margin-220.1%-110pp
Net margin-174,314.2%-62,763pp
FCF margin-154,209.2%-53,057pp

Returns & leverage

See full
Return on equity-45.4%+29.8pp
Debt / equity0×0.0×
Current ratio9.3×-3.0×

Where this comes from

Reported directly by 4D Molecular Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDerivativeLiabilities.

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's increase decrease in derivative liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 4D Molecular Therapeutics's increase decrease in derivative liabilities?
4D Molecular Therapeutics (FDMT) reported increase decrease in derivative liabilities of $12K in Q1 2026.
How has 4D Molecular Therapeutics's increase decrease in derivative liabilities changed year-over-year?
4D Molecular Therapeutics's increase decrease in derivative liabilities increased by 113.6% year-over-year, from -$88K to $12K.
What is the long-term trend for 4D Molecular Therapeutics's increase decrease in derivative liabilities?
Over 2 years (2022 to 2024), 4D Molecular Therapeutics's increase decrease in derivative liabilities has grown at a 352.8% compound annual growth rate (CAGR), from -$2K to $41K.
What does increase decrease in derivative liabilities mean?
Reflects the net change in the fair value of derivative financial instruments classified as liabilities on the balance sheet. Fluctuations in this metric indicate changes in the company's exposure to market risks or the valuation of embedded derivatives. A decrease typically represents a reduction in liability, while an increase indicates a rise in obligations related to derivative contracts.